ATE462780T1 - Stabile, herg darstellende zellkulturen - Google Patents
Stabile, herg darstellende zellkulturenInfo
- Publication number
- ATE462780T1 ATE462780T1 AT06125765T AT06125765T ATE462780T1 AT E462780 T1 ATE462780 T1 AT E462780T1 AT 06125765 T AT06125765 T AT 06125765T AT 06125765 T AT06125765 T AT 06125765T AT E462780 T1 ATE462780 T1 AT E462780T1
- Authority
- AT
- Austria
- Prior art keywords
- stable
- herg
- cell cultures
- representing cell
- representing
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Golf Clubs (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75301505P | 2005-12-21 | 2005-12-21 | |
| US84196506P | 2006-09-01 | 2006-09-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE462780T1 true ATE462780T1 (de) | 2010-04-15 |
Family
ID=37891741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06125765T ATE462780T1 (de) | 2005-12-21 | 2006-12-11 | Stabile, herg darstellende zellkulturen |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7776590B2 (de) |
| EP (1) | EP1801200B1 (de) |
| JP (1) | JP4464954B2 (de) |
| CN (1) | CN100516205C (de) |
| AT (1) | ATE462780T1 (de) |
| CA (1) | CA2571339C (de) |
| DE (1) | DE602006013258D1 (de) |
| ES (1) | ES2340604T3 (de) |
| SG (1) | SG133563A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101498723A (zh) * | 2009-02-27 | 2009-08-05 | 深圳先进技术研究院 | 离子通道药物筛选装置及方法 |
| CN116355835B (zh) * | 2023-03-30 | 2026-05-26 | 武汉合研生物医药科技有限公司 | 一种提高膜片钳试验时hERG-HEK293细胞稳定性的铺板方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2459265A1 (en) | 2001-09-04 | 2003-03-13 | Pfizer Inc. | Affinity-assay for the human erg potassium channel |
| SE0104251D0 (sv) * | 2001-12-14 | 2001-12-14 | Astrazeneca Ab | Novel compounds |
| US7510874B2 (en) * | 2003-10-28 | 2009-03-31 | Wisconsin Alumni Research Foundation | Stable cell lines expressing HERG1a and HERG1b |
| EP1690933B1 (de) * | 2003-11-17 | 2013-04-24 | Eisai R&D Management Co., Ltd. | Herg-kanal exprimierende zelle |
-
2006
- 2006-12-11 ES ES06125765T patent/ES2340604T3/es active Active
- 2006-12-11 EP EP06125765A patent/EP1801200B1/de active Active
- 2006-12-11 DE DE602006013258T patent/DE602006013258D1/de active Active
- 2006-12-11 US US11/637,511 patent/US7776590B2/en active Active
- 2006-12-11 AT AT06125765T patent/ATE462780T1/de not_active IP Right Cessation
- 2006-12-18 CA CA2571339A patent/CA2571339C/en active Active
- 2006-12-21 CN CNB2006101692448A patent/CN100516205C/zh active Active
- 2006-12-21 SG SG200608913-0A patent/SG133563A1/en unknown
- 2006-12-21 JP JP2006343699A patent/JP4464954B2/ja active Active
-
2010
- 2010-06-22 US US12/820,358 patent/US8349572B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2571339A1 (en) | 2007-06-21 |
| ES2340604T3 (es) | 2010-06-07 |
| EP1801200A1 (de) | 2007-06-27 |
| US8349572B2 (en) | 2013-01-08 |
| DE602006013258D1 (de) | 2010-05-12 |
| JP2007167068A (ja) | 2007-07-05 |
| US20070141554A1 (en) | 2007-06-21 |
| US20100261191A1 (en) | 2010-10-14 |
| CA2571339C (en) | 2010-05-04 |
| CN1986783A (zh) | 2007-06-27 |
| US7776590B2 (en) | 2010-08-17 |
| EP1801200B1 (de) | 2010-03-31 |
| JP4464954B2 (ja) | 2010-05-19 |
| SG133563A1 (en) | 2007-07-30 |
| CN100516205C (zh) | 2009-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2009001263S1 (es) | Maquina de afeitar. | |
| CL2009001380S1 (es) | Mango de maquina de afeitar. | |
| CL2007002182S1 (es) | Terminal. | |
| MX2009013706A (es) | Celulas multipotentes/pluripotentes y metodos relacionados. | |
| ATE538616T1 (de) | Steuerung der wachzeit einer mobilvorrichtung | |
| EP1951933A4 (de) | Kontinuierliche elektrochemische gleichstrom-reduktion von kohlendioxid | |
| NZ597438A (en) | Systems and methods for selecting a network access system | |
| BRPI0916851A2 (pt) | separação de dióxido de carbono e hidrogênio. | |
| CL2009000063S1 (es) | Mango para maquina de afeitar. | |
| MX346001B (es) | Polipeptidos de eritropoyetina animal modificados y sus usos. | |
| IN2014CN03629A (de) | ||
| CR9930A (es) | Compuestos | |
| MX2010002028A (es) | Metodos y composiciones para modular celulas t. | |
| BR112013033139A2 (pt) | métodos e equipamentos para aprimorar os mecanismos de atualização de parâmetros de nfc | |
| WO2007133488A3 (en) | Framework for agile mobile applications | |
| GEAP201813723A (en) | Anti-gcc antibody molecules and related compositions and methods | |
| CO6241120A2 (es) | (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS. | |
| CL2009001363S1 (es) | Pieza para maquina de afeitar. | |
| EA201171332A1 (ru) | Композиция для стерилизации поверхностей | |
| UY34360A (es) | ?compuestos de tipo bisamida con actividad insecticida, procesos e intermediarios? | |
| DE602006013258D1 (de) | Stabile, hERG darstellende Zellkulturen | |
| ATE556446T1 (de) | Batterieanoden | |
| WO2006006080A3 (en) | Sodium channel agonist | |
| ATE492133T1 (de) | Dynamische bereitstellung einer dienstqualität für einen mobilen knoten | |
| WO2009004664A3 (en) | Immortalized cell line of murine mesenchymal stem cells, method for preparation and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |